Birchview Capital, LP

Holdings History for Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Symbol: NKTR on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2023		-0.01%	$0	0	-28,000	-100%	$42.28	Q4 2023
30 Sep 2023	0.01%	0%	$16,677	28,000	0		$0.60	Q3 2023
30 Jun 2023	0.01%	-0.04%	$16,106	28,000	-90,000	-76%	$0.58	Q2 2023
31 Mar 2023	0.06%	0%	$83,000	118,000	0		$0.70	Q1 2023
31 Dec 2022	0.19%	-0.02%	$267,000	118,000	-10,000	-7.8%	$2.26	Q4 2022
30 Sep 2022	0.29%	0%	$410,000	128,000	0		$3.20	Q3 2022
30 Jun 2022	0.35%	0%	$486,000	128,000	0		$3.80	Q2 2022
31 Mar 2022	0.5%	+0.11%	$690,000	128,000	+28,000	+28%	$5.39	Q1 2022
31 Dec 2021	0.87%	+0.24%	$1,351,000	100,000	+28,000	+39%	$13.51	Q4 2021
30 Sep 2021	0.88%	0%	$1,293,000	72,000	0		$17.96	Q3 2021
30 Jun 2021	0.75%	-0.21%	$1,236,000	72,000	-20,000	-22%	$17.17	Q2 2021
31 Mar 2021	1.1%	+1.1%	$1,840,000	92,000	+92,000	NEW	$20.00	Q1 2021
30 Sep 2019		-0.21%	$0	0	-9,500	-100%	$42.28	Q3 2019
30 Jun 2019	0.21%	0%	$338,000	9,500	0		$35.58	Q2 2019
31 Mar 2019	0.2%	0%	$319,000	9,500	0		$33.58	Q1 2019
31 Dec 2018	0.3%	0%	$312,000	9,500	0		$32.84	Q4 2018
30 Sep 2018	0.37%	0%	$579,000	9,500	0		$60.95	Q3 2018
30 Jun 2018	0.32%	+0.32%	$464,000	9,500	+9,500	NEW	$48.84	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.